COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc develops novel medicines for the treatment of human viral diseases. It focuses on the development and commercialization of broad-spectrum antiviral drug candidates that transforms the treatment and prophylaxis of diseases in humans.

$1.41
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
05/03/2013
68,563,512
2,405,229
$94,617,647
0.00%
SEC Edgar Online
10-Q
10-K
19188J300
US19188J3005
BF5DYS4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-1.69
1.89
49.64
-111.60%
-2,938.09%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy